Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax

The PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Joana D'Arc Neves, Zanchi, Fernando Berton, Rodrigues, Francisco Lurdevanhe da Silva, Honda, Eduardo Rezende, Katsuragawa, Tony Hiroschi, Pereira, Dhélio Batista, Taborda, Roger Lafontaine Mesquita, Tada, Mauro Shugiro, Ferreira, Ricardo de Godoi Mattos, Pereira-da-Silva, Luiz Hildebrando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974312/
https://www.ncbi.nlm.nih.gov/pubmed/23440122
http://dx.doi.org/10.1590/S0074-02762013000100016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974312/
https://www.ncbi.nlm.nih.gov/pubmed/23440122
http://dx.doi.org/10.1590/S0074-02762013000100016

Ejemplares similares